Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Carboplatin and Etoposide with Stem Cell Rescue in Relapsed/Refractory Germ Cell Tumors
NCT00002508Phase 2Completed
- Sponsor
- Temple University
- Start
- Nov 1990
- Primary completion
- Sep 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, single-arm trial of carboplatin and etoposide in germ cell tumor (GCT), sponsored by Temple University. Primary endpoints: Objective Response Rate, Overall Survival and 1 more. Started Nov 1990; status: completed.
02
Drugs
carboplatinetoposide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00002508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002508.